Jennifer Cochran

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Biograph 55, Inc. is a biotechnology firm. The CEO of the American company is Paul C Tumeh.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation.

Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation.

Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation.

Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

Switch Bioworks, Inc. is a biofertilizer company based in San Carlos, CA. The company's mission is to feed the world sustainably by engineering naturally occurring microbes to become sustainable fertilizer producing factories directly on the roots of plants. The company produces microbes and formulate them into a powder, which farmers rehydrate to awaken and apply at crop sowing. The microbes first proliferate alongside germinating plants, and then switch on nitrogen fertilizer production through a proprietary mechanism. This process is more efficient, lower cost, and has no toxic gas emissions or runoff. The company was founded by Elizabeth Sattely, Tim Schnabel, Jim Swartz, Jennifer Cochran, and Amy L. Chang, with Tim Schnabel as the CEO since incorporation.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Lagunita Biosciences LLC (Lagunita Biosciences) is a venture Capital firm founded in 2015 by Mark S. Blumenkranz. The firm is headquartered in Menlo Park, California.

Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation.

Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California.

Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

Red Tree Venture Capital is a venture capital firm founded by Heath Lukatch. The firm is headquartered in portola, California.

Rondo Therapeutics, Inc. develops bispecific therapeutic antibodies to fight cancer. The American company was founded by Nathan D. Trinklein, Shelley Force Aldred. Shelley Force Aldred has been the CEO since incorporation.